Trial Profile
Clinical Trials Insight: 700013446
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jan 2010
Price :
$35
*
At a glance
- Drugs PRX 07034 (Primary)
- Indications Alzheimer's disease; Cognition disorders; Obesity; Schizophrenia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Predix Pharmaceuticals
- 27 Oct 2006 Status change
- 20 Jun 2006 New trial record.